Tesamorelin 10MG

A synthetic growth hormone-releasing hormone (GHRH) analogue comprised of the 44-amino acid sequence of human growth hormone-releasing factor modified with an N-terminal trans-3-hexenoic acid group. This N-terminal stabilization dramatically increases its resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation, providing a highly stable molecular tool for laboratory studies. It is widely investigated in endocrinology research for its selective mechanism of action in stimulating pituitary somatotrophs, upregulating endogenous growth hormone synthesis, and evaluating changes in adipose tissue distribution and metabolic signaling pathways.